aXichem AB (STO:AXIC.A)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.275
-0.005 (-0.39%)
Mar 6, 2026, 5:29 PM CET
-1.16%
Market Cap 75.37M
Revenue (ttm) 18.45M
Net Income (ttm) -17.63M
Shares Out 59.11M
EPS (ttm) -0.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,255
Average Volume 40,308
Open 1.280
Previous Close 1.275
Day's Range 1.240 - 1.280
52-Week Range 0.980 - 4.100
Beta -0.40
RSI 38.86
Earnings Date Feb 26, 2026

About aXichem AB

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. The company offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was founded in 1999... [Read more]

Sector Materials
Founded 1999
Employees 7
Stock Exchange Nasdaq Stockholm
Ticker Symbol AXIC.A
Full Company Profile

Financial Performance

In 2025, aXichem AB's revenue was 18.45 million, an increase of 115.24% compared to the previous year's 8.57 million. Losses were -17.63 million, -1.01% less than in 2024.

Financial Statements

News

There is no news available yet.